Amgen Drug Delivers More Weight Loss Than Competitors

A new weight loss drug developed by Amgen may provide better results with fewer injections than current treatments such as Ozempic and Wegovy, according to the results of a recent trial.

Trial participants who were obese or overweight lost an average of 20 percent of their body weight in 12 months without their weight loss plateauing, indicating that more weight could be lost if they stayed on the treatment, MariTide, for longer.